Matúš Igaz, Peter Ďurdík, Dominika Šutvajová, Veronika Kučeravá, Stanislava Suroviaková, Peter Bánovčin
ADHD is currently a disease that is often underestimated. Society often resonates the idea that the reason why children experience hyperactivity, inattentiveness, and impulsivity arise only from neglected parenting. Today’s medicine looks at ADHD as a neurodevelopmental brain disorder that limits the child’s daily functioning, not neglecting the impact on the family and the environment. However, the disease is not just child- related, and most non- treated patients with ADHD have clinical symptoms even in adulthood, which results in a furtherburden on society. Basic methods of therapy include psychoeducation and pharmacotherapy. Drug therapy uses psychostimulants and non-stimulants. However, the co- operation and consent of the parent with such treatment is very difficult to obtain and sustainable. Polyunsaturated omega-3 and omega-6 as essential fatty acids play a major role in the healthy development of the baby’s brain and are a promising choice of adjuvant therapy. Children with ADHD have, in addition to daytime, night signs, and thus the effect of supplementary polyunsaturated fatty acid therapy could be more objectively assessed by polysomnography – sleep examination. Changes in children with ADHD are also in their electrical brain activity and thus another additional examination in diagnosis as well as in assessing the effect of treatment appears to be EEG brain examination. It is these diagnostic methods that could further objectify the diagnosis of ADHD.